Curocell (XKRX:372320) EV-to-Revenue : (As of Jun. 05, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Curocell EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Curocell's enterprise value is ₩439,603.16 Mil. Curocell does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in Jun. 2023. Therefore, GuruFocus does not calculate Curocell's EV-to-Revenue at this moment.

The historical rank and industry rank for Curocell's EV-to-Revenue or its related term are showing as below:

XKRX:372320's EV-to-Revenue is not ranked ^*
in the Biotechnology industry.
Industry Median: 7.985
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-05), Curocell's stock price is ₩31600.00. Curocell does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023. Therefore, GuruFocus does not calculate Curocell's PS Ratio at this moment.

Curocell EV-to-Revenue Historical Data

The historical data trend for Curocell's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell EV-to-Revenue Chart

Curocell Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Curocell Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	-	-	-	-

Competitive Comparison of Curocell's EV-to-Revenue

For the Biotechnology subindustry, Curocell's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curocell's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curocell's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Curocell's EV-to-Revenue falls into.

Curocell EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Curocell's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	439603.155	/
	=

Curocell (XKRX:372320) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Curocell's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	31600.00	/
	=

Curocell EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Curocell's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell (XKRX:372320) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002

Website

https://www.curocellbtx.com

Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines